140 related articles for article (PubMed ID: 36551582)
41. Combining deep-inspiration breath hold and intensity-modulated radiotherapy for gastric mucosa-associated lymphoid tissue lymphoma: Dosimetric evaluation using comprehensive plan quality indices.
Choi SH; Park SH; Lee JJB; Baek JG; Kim JS; Yoon HI
Radiat Oncol; 2019 Apr; 14(1):59. PubMed ID: 30961618
[TBL] [Abstract][Full Text] [Related]
42. Conformal irradiation of concave-shaped PTVs in the treatment of prostate cancer by simple 1D intensity-modulated beams.
Fiorino C; Broggi S; Corletto D; Cattaneo GM; Calandrino R
Radiother Oncol; 2000 Apr; 55(1):49-58. PubMed ID: 10788688
[TBL] [Abstract][Full Text] [Related]
43. Treatment of left sided breast cancer for a patient with funnel chest: volumetric-modulated arc therapy vs. 3D-CRT and intensity-modulated radiotherapy.
Haertl PM; Pohl F; Weidner K; Groeger C; Koelbl O; Dobler B
Med Dosim; 2013; 38(1):1-4. PubMed ID: 22727550
[TBL] [Abstract][Full Text] [Related]
44. A dosimetric comparison of three-dimensional conformal radiotherapy, volumetric-modulated arc therapy, and dynamic conformal arc therapy in the treatment of non-small cell lung cancer using stereotactic body radiotherapy.
Rauschenbach BM; Mackowiak L; Malhotra HK
J Appl Clin Med Phys; 2014 Sep; 15(5):4898. PubMed ID: 25207575
[TBL] [Abstract][Full Text] [Related]
45. Evaluation of the dosimetric and radiobiological parameters in four radiotherapy regimens for synchronous bilateral breast cancer.
Kang SW; Kang S; Lee B; Song C; Eom KY; Jang BS; Kim IA; Kim JS; Cho W; Shin DS; Kim JY; Chung JB
J Appl Clin Med Phys; 2022 Aug; 23(8):e13706. PubMed ID: 35727562
[TBL] [Abstract][Full Text] [Related]
46. Intensity modulated and three-dimensional conformal radiation therapy plans for oropharyngeal cancer: a comparison of their sensitivity to set-up errors and uncertainties.
Ploquin N; Lau H; Dunscombe P
Curr Oncol; 2006 Apr; 13(2):61-6. PubMed ID: 17576443
[TBL] [Abstract][Full Text] [Related]
47. SU-E-T-577: Dosimetric Comparison of Volumetric Modulated Arc Therapy (VMAT), Step and Shoot and Sliding Window IMRT for Prostate Cancer.
Schnell E; De La Fuente Herman T; Algan O; Syzek L; Herman T; Young J; Hildebrand K; Ahmad S
Med Phys; 2012 Jun; 39(6Part19):3838. PubMed ID: 28517085
[TBL] [Abstract][Full Text] [Related]
48. Image-guided volumetric modulated arc therapy for breast cancer: a feasibility study and plan comparison with three-dimensional conformal and intensity-modulated radiotherapy.
Badakhshi H; Kaul D; Nadobny J; Wille B; Sehouli J; Budach V
Br J Radiol; 2013 Dec; 86(1032):20130515. PubMed ID: 24167182
[TBL] [Abstract][Full Text] [Related]
49. Radiobiological and dosimetric impact of RayStation pencil beam and Monte Carlo algorithms on intensity-modulated proton therapy breast cancer plans.
Rana S; Greco K; Samuel EJJ; Bennouna J
J Appl Clin Med Phys; 2019 Aug; 20(8):36-46. PubMed ID: 31343826
[TBL] [Abstract][Full Text] [Related]
50. Volumetric modulated arc therapy (VMAT) vs. serial tomotherapy, step-and-shoot IMRT and 3D-conformal RT for treatment of prostate cancer.
Wolff D; Stieler F; Welzel G; Lorenz F; Abo-Madyan Y; Mai S; Herskind C; Polednik M; Steil V; Wenz F; Lohr F
Radiother Oncol; 2009 Nov; 93(2):226-33. PubMed ID: 19765846
[TBL] [Abstract][Full Text] [Related]
51. Treatment plan comparison of volumetric-modulated arc therapy to intensity-modulated radiotherapy in lung stereotactic body radiotherapy using either 6- or 10-MV photon energies.
Wei Z; Peng X; He L; Wang J; Liu Z; Xiao J
J Appl Clin Med Phys; 2022 Aug; 23(8):e13714. PubMed ID: 35808973
[TBL] [Abstract][Full Text] [Related]
52. Dosimetric comparison of preoperative single-fraction partial breast radiotherapy techniques: 3D CRT, noncoplanar IMRT, coplanar IMRT, and VMAT.
Yoo S; Blitzblau R; Yin FF; Horton JK
J Appl Clin Med Phys; 2015 Jan; 16(1):5126. PubMed ID: 25679170
[TBL] [Abstract][Full Text] [Related]
53. Radiation-induced second primary cancer risks from modern external beam radiotherapy for early prostate cancer: impact of stereotactic ablative radiotherapy (SABR), volumetric modulated arc therapy (VMAT) and flattening filter free (FFF) radiotherapy.
Murray LJ; Thompson CM; Lilley J; Cosgrove V; Franks K; Sebag-Montefiore D; Henry AM
Phys Med Biol; 2015 Feb; 60(3):1237-57. PubMed ID: 25590229
[TBL] [Abstract][Full Text] [Related]
54. Volumetric modulation arc radiotherapy with flattening filter-free beams compared with static gantry IMRT and 3D conformal radiotherapy for advanced esophageal cancer: a feasibility study.
Nicolini G; Ghosh-Laskar S; Shrivastava SK; Banerjee S; Chaudhary S; Agarwal JP; Munshi A; Clivio A; Fogliata A; Mancosu P; Vanetti E; Cozzi L
Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):553-60. PubMed ID: 22386376
[TBL] [Abstract][Full Text] [Related]
55. Dosimetric comparison of intensity modulated radiotherapy isocentric field plans and field in field (FIF) forward plans in the treatment of breast cancer.
Al-Rahbi ZS; Al Mandhari Z; Ravichandran R; Al-Kindi F; Davis CA; Bhasi S; Satyapal N; Rajan B
J Med Phys; 2013 Jan; 38(1):22-9. PubMed ID: 23531607
[TBL] [Abstract][Full Text] [Related]
56. Volumetric-modulated arc therapy for the treatment of a large planning target volume in thoracic esophageal cancer.
Abbas AS; Moseley D; Kassam Z; Kim SM; Cho C
J Appl Clin Med Phys; 2013 May; 14(3):4269. PubMed ID: 23652258
[TBL] [Abstract][Full Text] [Related]
57. Voxel-Level BED Corrected Dosimetric and Radiobiological Assessment of 2 Kinds of Hybrid Radiotherapy Planning Methods for Stage III NSCLC.
Wang H; Huang Y; Chen H; Shao Y; Duan Y; Feng A; Gu H; Ma X; Xu Z; Kong Q; Zhou Y
Technol Cancer Res Treat; 2022; 21():15330338221107966. PubMed ID: 35731648
[No Abstract] [Full Text] [Related]
58. Radiobiological impact of planning techniques for prostate cancer in terms of tumor control probability and normal tissue complication probability.
Rana S; Cheng C
Ann Med Health Sci Res; 2014 Mar; 4(2):167-72. PubMed ID: 24761232
[TBL] [Abstract][Full Text] [Related]
59. Transitioning from conformal radiotherapy to intensity-modulated radiotherapy after radical prostatectomy: Clinical benefit, oncologic outcomes and incidence of gastrointestinal and urinary toxicities.
Flores-Balcázar CH; Urías-Arce DM; Bourlon MT; Gabilondo-Navarro F; Pérez-Álvarez SI; Ramos-Prudencio R; Rodríguez-Covarrubias F
Rep Pract Oncol Radiother; 2020; 25(4):568-573. PubMed ID: 32494230
[TBL] [Abstract][Full Text] [Related]
60. Dosimetric study of uniform scanning proton therapy planning for prostate cancer patients with a metal hip prosthesis, and comparison with volumetric-modulated arc therapy.
Rana S; Cheng C; Zheng Y; Hsi W; Zeidan O; Schreuder N; Vargas C; Larson G
J Appl Clin Med Phys; 2014 May; 15(3):4611. PubMed ID: 24892333
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
